Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00554671 · ClinicalTrials.gov registry record · NA

Pharmacist-led Group Medical Visits to Help With Diabetes Management

A NA study of Cardiovascular Diseases and Diabetes Mellitus, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
250
Enrollment target
3
Study locations

NCT00554671 is a NA study of Cardiovascular Diseases and Diabetes Mellitus that has completed, run by VA Office of Research and Development. The registered enrollment target is 250 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00554671, a NA study of Cardiovascular Diseases and Diabetes Mellitus, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
250 participants
Enrollment target
3
Study locations

Study Summary

This is a multi-site open label randomized controlled study of patients with type 2 diabetes undergoing pharmacist-led group medical visits that include education by a multi-disciplinary personnel, behavioral modification and pharmacotherapy case management vs. usual care

Interventions

  • BEHAVIORAL Monitoring
  • OTHER Algorithm driven medication titration
  • BEHAVIORAL Group support
  • BEHAVIORAL Self efficacy

Study Locations (3)

Connecticut

  • VA Connecticut Health Care System (West Haven) - West Haven

Hawaii

  • VA Pacific Islands Health Care System, Honolulu - Honolulu

Rhode Island

  • Providence VA Medical Center, Providence, RI - Providence

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2008-05
Est. Completion 2012-06
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00554671

The ClinicalTrials.gov registry entry for NCT00554671 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 4 interventions - of which Monitoring is the first listed.

NCT00554671 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Hawaii, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT00554671 about?

NCT00554671 is a clinical study titled "Pharmacist-led Group Medical Visits to Help With Diabetes Management". This is a multi-site open label randomized controlled study of patients with type 2 diabetes undergoing pharmacist-led group medical visits that include education by a multi-disciplinary personnel, behavioral modification and pharmacotherapy case management vs. usual care

What is the current status of trial NCT00554671?

This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2008-05. Estimated completion is 2012-06.

What conditions does trial NCT00554671 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Diabetes Mellitus.

What interventions are being tested in trial NCT00554671?

The interventions under investigation include: Monitoring (BEHAVIORAL), Algorithm driven medication titration (OTHER), Group support (BEHAVIORAL), Self efficacy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00554671?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00554671 being conducted?

This trial has 3 study locations across Connecticut, Hawaii, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.